Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors
Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.. Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.